Millennium Management’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Millennium Management’s Portfolio OCEA Stock Details OCEA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-124,895	Closed	-$69.1K	–	6555
2024 Q4	$69.1K	Sell	124,895 -2,667	-2%	-$2.1K	﹤0.01%	5543
2024 Q3	$125K	Sell	127,562 -40,571	-24%	-$43.5K	﹤0.01%	5543
2024 Q2	$205K	Buy	168,133 +154,911	+1,172%	+$264K	﹤0.01%	5131
2024 Q1	$50K	Buy	+13,222	New	+$24.9K	﹤0.01%	5686
2023 Q2	–	Sell	-28,493	Closed	-$189K	–	6806
2023 Q1	$189K	Sell	28,493 -71,507	-72%	-$604K	﹤0.01%	5195
2022 Q4	$1.04M	Hold	100,000	–	–	﹤0.01%	4122
2022 Q3	$1.02M	Sell	100,000 -1,120	-1%	-$11.4K	﹤0.01%	4325
2022 Q2	$1.02M	Buy	101,120 +1,120	+1%	+$11.3K	﹤0.01%	4344
2022 Q1	$1.01M	Buy	+100,000	New	+$1M	﹤0.01%	4502

Other funds holding OCEA

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VPIM

Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

RWP

Revolve Wealth Partners Hackensack, New Jersey $965M AUM 22.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management's OCEA Position: Q1 2025 in Review

Millennium Management sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q1 2025, closing a stake of 124,895 shares — an estimated $69.1K sold.

Millennium Management first reported a position in OCEA in Q1 2022 and held it in 9 quarters. The position peaked at $1.04M in Q4 2022. 25 funds tracked by Wall St. Rank hold OCEA as of Q1 2025.

Millennium Management reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Millennium Management sold 124,895 Ocean Biomedical, Inc. Common Stock shares in Q1 2025, an estimated $69.1K.
Millennium Management first reported a position in Ocean Biomedical, Inc. Common Stock in Q1 2022 and held it in 9 quarters.
Millennium Management's Ocean Biomedical, Inc. Common Stock position peaked at $1.04M in Q4 2022.
25 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q1 2025.

Based on Millennium Management's 13F filing for Q1 2025, filed 15 May 2025.